This message was sent to ##Email##
|
|
|
|
|
| |
| ACS CANCER PROGRAMS UPDATES |
NCBD
We are pleased to announce the NCDB reporting tools have been updated to include cases diagnosed in 2016. This update also includes newly diagnosed or updated cases for earlier diagnosis years submitted by CoC-accredited cancer programs during the 2018 NCDB Call for Data.
Updated data has been published in:
- Hospital Comparison Benchmark Reports
- Cancer Program Practice Profile Reports (CP3R)
- Public NCDB Benchmark Reports
Users are now able to view 2016 diagnoses in CP3R, the Hospital Comparison Benchmark Reports and the Public NCDB Benchmark Reports.
READ MORE
|
Promoted by
|
|
|
|
 |
ACS
The American College of Surgeons (ACS) has issued a call for abstracts to be presented at our 2019 Quality and Safety Conference, July 19-22, at the Walter E. Convention Center in Washington, D.C. The deadline for submitting abstracts is Feb. 1, 2019.
Individuals at participating sites are encouraged to submit a 250-word abstract for poster and/or podium presentation. The abstract should relate to surgical quality improvement initiatives including the development, implementation or validation of best practices within one or more of the following ACS Quality Programs:
- ACS National Surgical Quality Improvement Program (ACS NSQIP®)
- ACS Children’s Surgery Verification and ACS NSQIP Pediatric
- Cancer Programs, including the Commission on Cancer (CoC) and National Accreditation Program for Breast Centers (NAPBC)
- Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP)
- Trauma Quality Programs, including Pediatrics, Verification, Trauma Quality Improvement Program (TQIP), and Performance Improvement and Patient Safety
Upcoming deadlines
Abstract submissions close Feb. 1, 2019
Acceptance notices sent May 1, 2019
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
ACS
The Commission on Cancer (CoC) invites all practicing physicians at CoC-accredited programs to submit an application to join the CoC Surveyor Team. If you are passionate about the CoC and its Standards, we are looking for you! Consider becoming part of the CoC Surveyor Team and share your commitment for providing patients with high-quality, patient-centered, multidisciplinary care.
In order to meet the ever-increasing number of programs interested in CoC accreditation, we need your support and expertise. Click here to access the application.
If you have questions, please contact accreditation@facs.org.
ACS
At Clinical Congress 2018, the inaugural SurgeonsVoice Advocate of the Year award was presented to Alan G. Thorson, MD, FACS, a colon and rectal surgeon in Omaha, Nebraska, for his commitment to the American College of Surgeons (ACS) advocacy and political efforts, particularly through his involvement with the Commission on Cancer. Thorson will also be featured in the Bulletin of the American College of Surgeons.
READ MORE
ACS
April 7–9, 2019 – Rosemont (Chicago), Illinois
The 2019 Cluster Programs will be three individual one-day programs on consecutive days, in one location, for your convenience. You may attend just one program or all three. Sign up here for further information as it becomes available.
|
|
|
|
|
| |
AJCC
The AJCC Cancer Staging Manual, Eighth Edition is the first edition to have an electronic book (ebook) version. It is available for purchase now on Amazon and is the most current version of the manual (September 2018).
Since 1977, the American Joint Committee on Cancer (AJCC) has published eight editions of cancer staging manuals using contemporary, evidenced-based literature to build a common language of cancer for the care of cancer patients by clinicians and for the cancer surveillance community. The print version of the eighth edition was first published in October 2016 and went into effect for all cancer cases diagnosed on or after Jan. 1, 2018. The eighth edition presents evidence-based revisions for the staging of cancer for a number of organ sites. The chapters include the rationale and rules for staging; the definitions of tumor, lymph node involvement and metastasis; stage groupings; and histologic grade.
There have been updates since the first printing of the eighth edition, all of which are incorporated in this ebook version available through Amazon’s Kindle. The Kindle version can be used on any device (PC, MAC, iPhone, iPad, Android) with the free Kindle app. The electronic version allows for highlighting, adding notes and bookmarks and creating flashcards. The AJCC has a curated FAQ document to address common questions that can be accessed at cancerstaging.org. All other questions related to the eighth edition can be sent to ajcc@facs.org.
READ MORE
|
Promoted by
|
|
|
|
 |
NCCRT
The 2017 national average for CRC screening in HRSA-funded health centers was released last month and is at 42 percent, which increased from 39.9 percent in 2015, meaning an additional 223,100 patients were screened in the last year alone and an additional 467,500 patients were screened in the last 2 years. That’s almost half a million people! Visit the HRSA website for an additional understanding of the rates. View our 80 percent by 2018 Hall of Fame to see the list of these centers that are meeting or exceeding our shared goal. (And if you or a partner you know of is exceeding 80 percent, you can submit them to the Hall of Fame!) Thanks to Laura Makaroff for sharing the data. Most importantly, congratulations to all our colleagues working in health centers, as well as to the many of you who work to support health centers on this continued improvement!
READ MORE
| HEALTH CARE NEWS AND UPDATES |
ScienceDaily
Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system.
The system, called LION LBD and developed by computer scientists and cancer researchers at the University of Cambridge, has been designed to assist scientists in the search for cancer-related discoveries. It is the first literature-based discovery system aimed at supporting cancer research. The results are reported in the journal Bioinformatics.
READ MORE
 |
|
Need to automate cancer coding at Budget Preserving costs? Let AI do the bulk coding and preserve valuable staff time for the most cryptic. HORIZON suite automates NAACR 2018 for 100% of your reportability assessments and 90%+ of your coding at better than manual accuracy, while undercutting manual costs. With ever-tightening budgets and workloads rising continuously and more data for analysis being demanded, www.hla-global.com
is your best option for the future.
|
|
Medical Xpress
As tumors develop, they evolve genetically. How does the immune system act when faced with tumor cells? How does it exert pressure on the genetic diversity of cancer cells? Scientists from the Institut Pasteur and Inserm used in vivo video techniques and cell-specific staining to visualize the action of immune cells in response to the proliferation of cancer cells.
READ MORE
Phys.Org
A technique to get more information from the blood of cancer patients than previously possible has been developed.
The discovery could potentially accelerate early diagnosis, speed up drug discovery and lead to advancements in personalized medicines. The Cancer Research UK-funded study was published in Advanced Materials recently.
READ MORE
Genonme Web
A study published recently by researchers from the Karolinska Institute in Sweden has added robust new data on the ability of liquid biopsy to detect a range of tumor-associated genomic alterations in the blood of advanced prostate cancer patients.
Although biomarker-directed therapy is in its infancy in prostate cancer compared with some other tumor types, there is a great need for predictive biomarker testing, and great interest in noninvasive methods, the authors wrote. However, comprehensive analysis of patients' cell-free DNA has been limited to date.
READ MORE
MD Magazine
New data from a small study suggest immunotherapy is safe in patients with HIV infection who are taking antiretroviral therapy.
The results were presented at the European Society for Medical Oncology’s ESMO 18 Congress in Munich. Though the results would need to be confirmed in larger studies, they are a promising sign that game-changing breakthroughs in both cancer therapy and HIV treatment can be effective in the same patients at the same time.
READ MORE
USA Today
A cutting-edge cancer treatment focusing on genetic biomarkers rather than any specific type of cancer has won accelerated approval from the Food and Drug Administration.
The recent approval for Vitrakvi, the brand name for larotrectinib, marks a new method for developing cancer drugs that are “tissue agnostic” — cancer that is not specific to one organ such as colon or breast cancer.
READ MORE
Medical Xpress
Research shows that up to 50 percent of cancer cases and deaths are preventable. Cancer prevention is the most cost-effective and sustainable long-term strategy for the control of cancer.
Over decades of research, what causes cancer and what is known about cancer prevention is still evolving. Nevertheless, experts at National Institute of Health, USA are recommending that our chances of developing cancer are affected by our lifestyle choices. Cancer is not a single disease but a group of related diseases where many things in our genes, our lifestyle and the environment around us may increase or decrease our risk of getting cancer.
READ MORE
AJMC
Cancer-related cognitive impairment — sometimes called “chemo brain” — is a pervasive phenomenon that can negatively impact patients’ quality of life and lead to depression, anxiety and fatigue. Studies of the cognitive performance of patients with breast cancer before and after chemotherapy have demonstrated that patients experience significant declines in cognitive function scores following treatment.
READ MORE
Women's Health
Most people are aware that there are some risks when it comes to getting breast implants — like scarring and infection, to name a few.
But now, a new NBC News report points out that there’s one more thing people should consider: Breast implants may be linked to a certain type of cancer.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
features posts on the industry, careers and more:
